Addition of Immunotherapy to Standard Treatment for Advanced Stage Non-Small Cell Lung Cancer is Saf
Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time ... Read more